| Structure | Chemical Name | CAS | MF |
|
3-Pyridinethiol,2-amino-5-methyl-(9CI)
|
110402-25-0
|
C6H8N2S
|
|
3-Pyridinethiol,2-aMino-5-chloro-
|
110402-26-1
|
C5H5ClN2S
|
|
3-Pyridinethiol,2-amino-4-methyl-(9CI)
|
110402-27-2
|
C6H8N2S
|
|
Oxalyl phosphate
|
110403-67-3
|
C2H3O7P
|
|
13-methyl-13-dihydrodaunorubicin
|
110403-82-2
|
C27H32ClNO9
|
|
2-chloro-6-(pyrrolidin-1-yl)benzaldehyde
|
110405-86-2
|
C11H12ClNO
|
|
4-[2-(Chloromethyl)Phenyl]Morpholine(WX630204)
|
110405-99-7
|
C11H14ClNO
|
|
1(2H)-Phthalazinone,4-[(4-fluorophenyl)methyl]-2-[hexahydro-1-(2-phenylethyl)-1H-azepin-4-yl]-,hydrochloride (1:1)
|
110406-33-2
|
C29H30FN3O.ClH
|
|
1(2H)-Phthalazinone, 2-(1-(2-(4-chlorophenyl)ethyl)hexahydro-1H-azepin -4-yl)-4-((4-chlorophenyl)methyl)-, monohydrochloride
|
110406-41-2
|
|
|
1(2H)-Phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-(3-phen ylpropyl)-1H-azepin-4-yl)-, hydrochloride, hydrate (1:1:1)
|
110406-46-7
|
C30H32ClN3O.ClH.H2O
|
|
4-[(4-fluorophenyl)methyl]-2-[1-[3-(4-fluorophenyl)propyl]-4-piperidyl ]phthalazin-1-one hydrochloride
|
110406-61-6
|
C29H30ClF2N3O
|
|
1(2H)-Phthalazinone, 2-(1-(cyclopropylmethyl)-4-piperidinyl)-4-((4-flu orophenyl)methyl)-, monohydrochloride
|
110406-69-4
|
|
|
Benzoic acid, 2-(hexahydro-1-Methyl-1H-azepin-4-yl)hydrazide
|
110406-94-5
|
C14H21N3O
|
|
3-(3,4-Dimethoxyphenyl)-1-chloropropane
|
110406-97-8
|
C11H15ClO2
|
|
1-(2-Benzhydryloxy-ethyl)-piperazine dihydrochloride
|
110407-21-1
|
C19H26Cl2N2O
|
|
benzyloxycarbonylalanyl-alanyl-prolyl-valine-trifluoromethyl ketone
|
110407-54-0
|
C25H33F3N4O6
|
|
2H-Pyran-3-carboxylicacid,tetrahydro-6-methoxy-(9CI)
|
110407-56-2
|
C7H12O4
|
|
Ethyl 5-hydroxy-tetrahydro-pyran-2-carboxylate
|
110407-58-4
|
C8H14O4
|
|
1-Bromo-2-chloro-4-fluorobenzene
|
110407-59-5
|
C6H3BrClF
|
|
1-[2-(Dimethoxymethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine
|
110408-09-8
|
C18H28N2O3
|
|
CKI-8
|
110408-10-1
|
C13H14ClN3O2S
|
|
1-(8-Chloro-5-isoquinolinesulfonyl)piperazine, dihydrochloride
|
110408-12-3
|
C13H14ClN3O2S
|
|
Oxirane, 2-ethynyl-3-pentyl-, (2R,3R)-rel- (9CI)
|
110411-08-0
|
C9H14O
|
|
5-Isoxazolol,3-(trifluoromethyl)-(9CI)
|
110411-51-3
|
C4H2F3NO2
|
|
5-Isoxazolol,4-methyl-3-(trifluoromethyl)-(9CI)
|
110411-53-5
|
C5H4F3NO2
|
|
Gelsemiol
|
110414-77-2
|
C10H16O4
|
|
b-D-Arabinofuranoside, Methyl, triacetate
|
110415-62-8
|
C12H18O8
|
|
Methyl 2,3,5-tri-O-acetylpentofuranoside
|
110415-63-9
|
C12H18O8
|
|
delta2-Avermectin B1a
|
110415-68-4
|
C48H72O14
|
|
dolastatin 10
|
110417-88-4
|
C42H68N6O6S
|
|
1,3-Dinitrofluoranthene
|
110419-21-1
|
C16H8N2O4
|
|
1-methyl-5-(2-deoxy-2-fluoroarabinofuranosyl)uracil
|
110419-25-5
|
C10H13FN2O5
|
|
Naphth[2,3-d]imidazole, 2-amino-5,6,7,8-tetrahydro- (6CI)
|
110422-95-2
|
C11H13N3
|
|
bis(1,3-dibutylbarbiturate)trimethine oxonol
|
110425-49-5
|
C27H40N4O6
|
|
Ethyl 2-methyl-3-(methylamino)propanoate
|
110427-00-4
|
C7H15NO2
|
|
2,4-Imidazolidinedione, 5,5-diphenyl-3-ethyl-1-(2-hydroxy-3-(1-piperid inyl)propyl)-, monohydrochloride
|
110427-55-9
|
C25H32ClN3O3
|
|
11β-Hydroxy-16α-Methyl-17,20:20,21-bis(Methylenedioxy)-pregn-1,4-dien-3-one
|
110428-42-7
|
C24H32O6
|
|
21-Amino-17-hydroxypregn-4-ene-3,11,20-trione hydrochloride
|
110428-56-3
|
C21H29NO4.ClH
|
|
3-hydroxyquinoline-2-carboxylic acid
|
110429-27-1
|
|
|
PAROXETINE-D4 HCL
|
110429-35-1
|
C19H23ClFNO4
|
|
N-Methylparoxetine
|
110429-36-2
|
C20H22FNO3
|
|
4-Pyrimidinemethanol, 2-amino-6-methyl- (9CI)
|
110429-43-1
|
C6H9N3O
|
|
Triethylene Glycol 2-Bromoethyl Methyl Ether
|
110429-45-3
|
C9H19BrO4
|
|
Hexa-sodium-benzene-hexathiolate
|
110431-65-7
|
C6H7NaS6
|
|
[2-diethylammonio-1-[(2-ethoxycarbonylphenyl)carbamoyl]ethyl]-diethyl- azanium dichloride
|
110437-09-7
|
C20H34ClN3O3
|
|
Titanium, 2,2-bis(2-propenyloxy-.kappa.O)methyl-1-butanolato-.kappa.Otris(dioctyl phosphato-.kappa.O)-, (OC-6-32)-
|
110438-25-0
|
C60H123O15P3Ti
|
|
Piperazine, polymer with (chloromethyl)oxirane, compd. with (chloromethyl)benzene
|
110438-26-1
|
C14H22Cl2N2O
|
|
diethyl-(tert-butylcarbamoylmethyl)azanium chloride
|
110438-99-8
|
C10H23ClN2O
|
|
1-Piperazinebutanol,4-ethyl-(6CI)
|
110439-00-4
|
C10H22N2O
|
|
4-[5-(4-methoxyphenoxy)pentoxy]aniline
|
110443-23-7
|
C18H23NO3
|
|
Direct blue 290
|
110444-91-2
|
|
|
|
REGOPAR
|
110445-23-3
|
|
|
|
ranolazine
|
110445-25-5
|
C24H33N3O4
|
|
ethyl 6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
|
110448-29-8
|
C14H15N3O5
|
|
ML-9
|
110448-31-2
|
C15H17ClN2O2S
|
|
ML-7 hydrochloride
|
110448-33-4
|
C15H18ClIN2O2S
|
|
5-Iodonaphthalene-1-sulfonylchloride
|
110448-35-6
|
C10H6ClIO2S
|
|
1-[3-(4-Methylphenyl)-1,2,4-oxadiazol-5-yl]acetone
|
110449-27-9
|
C12H12N2O2
|
|
L-Alanine, 3-[[(4-methylphenyl)methyl]sulfinyl]-
|
110449-58-6
|
C11H15NO3S
|
|
Methyl benzo[b]thiophene-7-carboxylate
|
110449-94-0
|
C10H8O2S
|
|
(2-Bromo-5-methoxy-3-methylphenyl)methanol
|
110451-90-6
|
C9H11BrO2
|
|
(6-Bromo-3-methoxy-2-methylphenyl)methanol
|
110451-91-7
|
C9H11BrO2
|
|
2-Methyl-2-p-tolylsulfanyl-propionaldehyde
|
110452-12-5
|
C11H14OS
|
|
Meso-Tetra(4-tert-butylphenyl) Porphine
|
110452-48-7
|
C60H62N4
|
|
D-Proline, 5-(1-methylethyl)-, (5S)-rel- (9CI)
|
110452-52-3
|
C8H15NO2
|
|
D-Proline, 5-(1-methylethyl)-, cis- (9CI)
|
110452-53-4
|
C8H15NO2
|
|
L-Proline, 5-(1-methylethyl)-, cis- (9CI)
|
110452-55-6
|
C8H15NO2
|
|
L-Proline, 5-(1-methylethyl)-, trans- (9CI)
|
110452-58-9
|
C8H15NO2
|
|
Forskolin, 7beta-deacetyl-7beta-[gamma-(morpholino) butyryl]-, hydrochloride
|
110452-74-9
|
C28H45NO8
|
|
Forskolin, 6beta-[beta'-(piperidino)propionyl]-, hydrochloride
|
110452-77-2
|
C30H47NO8
|
|
1-Azabicyclo[3.2.0]hept-3-ene-2-carboxylicacid,7-oxo-,(2S-cis)-(9CI)
|
110453-77-5
|
C7H7NO3
|
|
(S)-(+)-6-Methyl-1-octanol
|
110453-78-6
|
C9H20O
|
|
2-MethylaMino-nicotinic acid Methylester
|
110457-42-6
|
C8H10N2O2
|
|
1,2-dipalmitoyl-sn-glycerol 3-((((4-azido-2-nitrophenyl)amino)ethyl)phosphate)
|
110457-62-0
|
|
|
2-Amino-8-(2-deoxy-b-D-ribofuranosyl)-imidazo[1,2-a]-1,3,5-triazin-4(8H)-one
|
110457-87-9
|
C10H13N5O4
|
|
2-methoxy-1-[4-(oxiranylmethoxy)phenyl]ethanone
|
110458-44-1
|
C12H14O4
|
|
3-(4-(1-hydroxy-2-methoxyethyl)phenoxy)-1-(isopropylamino)-2-propanol
|
110458-46-3
|
C15H25NO4
|
|
ARBOZOL
|
110458-85-0
|
C13H20O
|
|
Acetamide, N-methyl-N-(2-methyl-6-benzothiazolyl)- (9CI)
|
110460-00-9
|
C11H12N2OS
|
|
2-[2-(Methylamino)ethyl]-1H-isoindole-1,3(2H)-dione, HCl salt
|
110460-11-2
|
C11H13ClN2O2
|
|
3-Oxo-6-phenyl-3,4-dihydropyrazine-2-carboxylic acid
|
110460-18-9
|
C11H8N2O3
|
|
4-methoxy-3,5-dimethylpicolinaldehyde
|
110464-72-7
|
C9H11NO2
|
|
2-Chloro-3,5-dimethyl-4-methoxy pyridine hydrochloride
|
110464-98-7
|
C8H10ClNO
|
|
1-(4-(2-Hydroxyethyl)-1-piperazine-2-propanolo)-3-ethyl-5,5-diphenylhy dantoin 2HCl hydrate
|
110465-03-7
|
C26H34N4O4.2ClH.H2O
|
|
1-(4-fluorophenyl)-1-(4-(2-N,N-diethylamino)ethoxy)phenyl-2-phenylethylene
|
110465-94-6
|
C26H28FNO
|
|
[(4-Aminophenyl)hydroxymethylene]bisphosphonic acid
|
110466-06-3
|
C7H11NO7P2
|
|
7-benzyl-9-phenyl-9-piperidino-3-oxa-7-azabicyclo(3.3.1)nonane
|
110466-16-5
|
C25H32N2O
|
|
3H-Pyrrole,2,3,3,5-tetramethyl-(9CI)
|
110466-33-6
|
C8H13N
|
|
2H-Pyrrole,3,4-dihydro-3,3,5-trimethyl-2-methylene-(9CI)
|
110466-34-7
|
C8H13N
|
|
2H-Pyrrole,3,4-dihydro-4,4,5-trimethyl-2-methylene-(9CI)
|
110466-35-8
|
C8H13N
|
|
L-Alanine, 3-[(1-oxo-2-propynyl)amino]- (9CI)
|
110469-17-5
|
C6H8N2O3
|
|
4-(trimethylsilyl)but-3-ynoic acid
|
110469-24-4
|
C7H12O2Si
|
|
1-tert-Butylpiperazine dihydrochloride
|
110469-59-5
|
C8H20Cl2N2
|
|
3-Cyclohexen-1-ol,6-(1-piperazinyl)-(9CI)
|
110469-60-8
|
C10H18N2O
|
|
1-(1,1-dioxidotetrahydro-3-thienyl)piperazine(SALTDATA: 2HCl)
|
110469-63-1
|
C8H16N2O2S
|
|
BABB
|
110471-15-3
|
C32H24N2O4
|
|
6-AMino-3-propylpyriMidine-2,4(1H,3H)-dione
|
110472-90-7
|
C7H11N3O2
|
|
5-Ethyl-1H-pyrazol-3-ol
|
110475-21-3
|
C5H8N2O
|
|
Imidazole-4(or 5)-carboxylic acid, 2-methyl-, hydrazide (6CI)
|
110475-22-4
|
C5H8N4O
|
|
1-Benzylpiperazine
|
110475-31-5
|
C11H17ClN2
|